Last reviewed · How we verify

Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis

NCT04462055 TERMINATED

This study evaluates the effectiveness of Dupilumab in food allergic patients with moderate to severe Atopic Dermatitis (AD). Included patients participated in the BioDay Registry.

Details

Lead sponsorUMC Utrecht
StatusTERMINATED
Enrolment3
Start dateWed May 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri Jul 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Countries

Netherlands